Twist Bioscience (TWST) Operating Expenses: 2018-2025
Historic Operating Expenses for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to $128.9 million.
- Twist Bioscience's Operating Expenses rose 6.78% to $128.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $512.8 million, marking a year-over-year decrease of 3.93%. This contributed to the annual value of $512.8 million for FY2025, which is 3.93% down from last year.
- Twist Bioscience's Operating Expenses amounted to $128.9 million in Q3 2025, which was up 2.19% from $126.2 million recorded in Q2 2025.
- In the past 5 years, Twist Bioscience's Operating Expenses ranged from a high of $170.4 million in Q2 2024 and a low of $69.2 million during Q1 2021.
- Over the past 3 years, Twist Bioscience's median Operating Expenses value was $124.2 million (recorded in 2024), while the average stood at $128.2 million.
- Its Operating Expenses has fluctuated over the past 5 years, first surged by 60.71% in 2021, then dropped by 25.95% in 2025.
- Twist Bioscience's Operating Expenses (Quarterly) stood at $98.0 million in 2021, then grew by 0.93% to $98.9 million in 2022, then climbed by 19.83% to $118.5 million in 2023, then increased by 4.12% to $123.4 million in 2024, then increased by 6.78% to $128.9 million in 2025.
- Its Operating Expenses was $128.9 million in Q3 2025, compared to $126.2 million in Q2 2025 and $134.4 million in Q1 2025.